Filter the drugs by their status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Latest database update
Number of references
(1,3-Dimethylpyrazol-4-yl)-[4-(4-fluorophenyl)piperazin-1-yl]methanone Potential treatment - theoretical effect Experimental Antiviral Oct/23/2020 Oct/26/2020 0
Ac-QS5-VS Potential treatment - pre-clinical evidence Experimental Antiviral Oct/22/2020 Oct/26/2020 0
ACE2 receptor trap Potential treatment - pre-clinical evidence Experimental Antiviral Oct/22/2020 Oct/26/2020 0
Remdesivir Approved by FDA Experimental Antiviral Oct/20/2020 Oct/29/2020 0
EpiVacCorona Approved (Russia) Experimental Vaccine Oct/15/2020 Oct/16/2020 0
E-M peptide Potential treatment - theoretical effect Experimental Antiviral Oct/14/2020 Oct/26/2020 0
Ebselen Potential treatment - theoretical effect Experimental Antiviral Oct/04/2020 Oct/04/2020 0
L1 Azo imidazole derivative Potential treatment - theoretical effect Experimental Antiviral Oct/02/2020 Oct/02/2020 0
L2 Azo imidazole Potential treatment - theoretical effect Experimental Antiviral Oct/02/2020 Oct/02/2020 0
L3 Azo imidazole Potential treatment - theoretical effect Experimental Antiviral Oct/02/2020 Oct/02/2020 0